Expertise in
5
conditions

Vincent Dubee

Angers, FR 
Expertise in
5
conditions
Angers, FR 

Overview

Vincent Dubee practices practicing medicine in Angers, France.

Mr. Dubee is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Endocarditis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Pneumonia.

He is actively involved in clinical research, co-authoring 115 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Angers, 49933, France
Other Locations
Nantes, France
Lyon, France
184 Rue Du Faubourg Saint Antoine, Paris Cedex 12, Paris, 75571, France
Inserm, France
Clichy-sous-bois, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Other
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: March 01, 2023
Intervention Type: Drug
Study Drugs: Hydroxychloroquine, Lopinavir, Ritonavir
Study Phase: Phase 3
View 1 Less Clinical Trial

115 Total Publications

The orphan receptor GPR84 drives inflammation in Buruli ulcer development.
The orphan receptor GPR84 drives inflammation in Buruli ulcer development.
Journal: Science translational medicine
Published: April 15, 2026

Frequently Asked Questions about Vincent Dubee

Is Vincent Dubee a top-rated expert for Endocarditis?

MediFind is an objective health platform that identifies experts based on real-world data. Vincent Dubee is classified as an Advanced expert for Endocarditis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vincent Dubee participate in research or clinical trials?

Yes. Vincent Dubee has published 115 articles and abstracts on conditions like Endocarditis. You can view a list of Vincent Dubee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dubee's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile